Impact of increasing ondansetron use on clinical outcomes in children with gastroenteritis

JAMA Pediatrics

Volumn 168, Issue 4, 2014, Pages 321-329

  Freedman, Stephen B ^a   Hall, Matt ^b   Shah, Samir S ^c   Kharbanda, Anupam B ^d   Aronson, Paul L ^e   Florin, Todd A ^c   Mistry, Rakesh D ^f   Macias, Charles D ^g   Neuman, Mark I ^h  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b CHILDREN S HOSPITAL ASSOCIATION   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g CENTER FOR CLINICAL STUDIES   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON;

ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; DEMOGRAPHY; DIAGNOSTIC IMAGING; EMERGENCY WARD; FEMALE; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REHYDRATION; ROTAVIRUS INFECTION; SCHOOL CHILD; TIME SERIES ANALYSIS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; FLUID THERAPY; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; ONDANSETRON; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84898441616     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.4906     Document Type: Article

References (29)

1. Freedman SB, Steiner MJ, Chan KJ. Oral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysis. PLoS Med. 2010;7(10): e1000350. doi:10.1371/journal .pmed.1000350(10).
2. Hartling L, Bellemare S,Wiebe N, Russell K, Klassen TP, CraigW. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev. 2006;3(3):CD004390.
3. Spandorfer PR, Alessandrini EA, Joffe MD, Localio R, Shaw KN. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics. 2005;115(2):295-301.
4. Bender BJ, Ozuah PO, Crain EF. Oral rehydration therapy: is anyone drinking? Pediatr Emerg Care. 2007;23(9):624-626.
5. Chow CM, Leung AK, Hon KL. Acute gastroenteritis: from guidelines to real life. Clin Exp Gastroenterol. 2010;3:97-112.
6. Ozuah PO, Avner JR, Stein RE. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics. 2002;109(2):259-261.
7. Sandhu BK, Isolauri E,Walker-Smith JA, et al. A multicentre study on behalf of the European Society of Paediatric Gastroenterology and NutritionWorking Group on Acute Diarrhoea: early feeding in childhood gastroenteritis. J Pediatr Gastroenterol Nutr. 1997;24(5):522-527.
8. DeCamp LR, Byerley JS, Doshi N, Steiner MJ. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2008;162(9):858-865.
9. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006;354(16):1698-1705.
10. Freedman SB, Tung C, Cho D, Rumantir M, Chan KJ. Time-series analysis of ondansetron use in pediatric gastroenteritis. J Pediatr Gastroenterol Nutr. 2012;54(3):381-386.
11. Roslund G, Hepps TS,McQuillen KK. The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial. Ann Emerg Med. 2008;52(1): 22-29, e6.
12. Ramsook C, Sahagun-Carreon I, Kozinetz CA, Moro-Sutherland D. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med. 2002;39(4):397-403.
13. Kharbanda AB, HallM, Shah SS, et al. Variation in resource utilization across a national sample of pediatric emergency departments. J Pediatr. 2013;163(1):230-236.
14. King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16.
15. Sturm JJ, Hirsh DA, Schweickert A, Massey R, Simon HK. Ondansetron use in the pediatric emergency department and effects on hospitalization and return rates: are we masking alternative diagnoses? Ann Emerg Med. 2010;55(5):415-422.
16. US Food and Drug Administration. FDA drug safety podcast for healthcare professionals: new information regarding QT prolongation with ondansetron (Zofran). http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm310546.htm. Accessed September 5, 2012.
17. Flay BR. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med. 1986;15(5):451-474.
18. Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA. 2008;299(17): 2048-2055.
19. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001;107(6):99.
20. Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness reviews. http://effectivehealthcare. ahrq.gov/ehc/products/60/318/CER-Methods-Guide-140109.pdf. Accessed January 23, 2014.
21. Jacobstein CR, Alessandrini EA, Lavelle JM, Shaw KN. Unscheduled revisits to a pediatric emergency department: risk factors for children with fever or infection-related complaints. Pediatr Emerg Care. 2005;21(12):816-821.
22. Mittal MK, Zorc JJ, Garcia-Espana JF, Shaw KN. An assessment of clinical performance measures for pediatric emergency physicians. Am J Med Qual. 2013;28(1):33-39.
23. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309.
24. Campbell DT, Stanley JC. Experimental and Quasi-experimental Designs for Research. Dallas, TX: Houghton Mifflin Co; 1963.
25. Herring A,Wilper A, Himmelstein DU, et al. Increasing length of stay among adult visits to US emergency departments, 2001-2005. Acad Emerg Med. 2009;16(7):609-616.
26. Neuman MI, Ting SA, Meydani A, Mansbach JM, Camargo CA Jr. National study of antibiotic use in emergency department visits for pneumonia, 1993 through 2008. Acad Emerg Med. 2012;19(5):562-568.
27. US Food and Drug Administration. FDA drug safety communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron). http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm. Accessed March 8, 2012.
28. Ayanian JZ, Van derWees PJ. Tackling rising health care costs in Massachusetts. N Engl J Med. 2012;367(9):790-793.
29. Reeves JJ, Shannon MW, Fleisher GR. Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics. 2002;109(4):e62.